Most of the diseases that we know as rare, minority or uncommon are due to inherited metabolic disorders. They are generally multisystemic, chronic, progressive and sometimes disabling diseases. Progress in the early diagnosis and treatment of these diseases has led to an increasing number of patients reaching adulthood, making it necessary to adapt to this new situation and provide adequate care for these diseases, traditionally considered to be paediatric.